AGP Executive Report
Last update: 3 hours agoRegulatory Update (Colombia): Knight Therapeutics won INVIMA approval for TAVALISSE (fostamatinib) to treat adult chronic immune thrombocytopenia patients who didn’t respond to, lost response to, or couldn’t tolerate prior steroids or IV immunoglobulin. Cancer Diagnostics (U.S.-aligned): Telix says it completed enrollment in its Phase 3 BiPASS study for prostate cancer imaging before biopsy, and aligned with the FDA on an NDA pathway that could expand reimbursement and access to 68Ga-PSMA PET. Mental Health & Genetics: A Rutgers-led international study identified 36 risk genes linked to OCD and chronic tic disorders, pointing to new shared biological pathways. Public Health Security (Caribbean): St. Vincent and the Grenadines became the first OECS member state to adopt CARPHA’s Regional Integrated Early Warning Surveillance and Response System under a World Bank-backed project. Local Health Leadership (St. Kitts & Nevis): Prime Minister Terrance Drew was hospitalized, then cleared as stable and set for overseas specialized observation; Geoffrey Hanley will act as PM. Health & Culture: A feature explores hair loss in Black and Caribbean women, stressing scalp health and timely care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
